Current Issue June 2012, Vol. 12, No. 3

Issue Highlights

Review

  • The Next Generation of Biologic Agents: Therapeutic Role in Relation to Existing Therapies in Metastatic Breast Cancer
    June 2012(Vol. 12 | No. 3 | Pages 157-166)

    PierFranco Conte, Valentina Guarneri

Original Studies

  • A Phase I Study of Ixabepilone in Combination With Epirubicin in Patients With Metastatic Breast Cancer
    June 2012(Vol. 12 | No. 3 | Pages 167-174)

    Henri Roché, Elena De Benedictis, Ewa Cottura, Silvia Govi, Florence Dalenc, Alberta Locatelli, Marion Deslandres, Milvia Zambetti, Laurence Gladieff, Marianne Messina, Luca Gianni

  • Effect of Different Doses of Metformin on Serum Testosterone and Insulin in Non-Diabetic Women With Breast Cancer: A Randomized Study
    June 2012(Vol. 12 | No. 3 | Pages 175-182)

    Carlo Campagnoli, Patrizia Pasanisi, Chiara Abbà, Simona Ambroggio, Nicoletta Biglia, Tiziana Brucato, Raffaella Colombero, Saverio Danese, Michela Donadio, Elisabetta Venturelli, Gianna Zito, Franco Berrino

  • An 81-Year-Old Patient With Distant Metastasis of Invasive Lobular Carcinoma Occurring 41 Years After Mastectomy
    18 May 2012

    Foluso O. Ademuyiwa, Thaer Khoury, John Warner, James Gannon, Helena Hwang

  • Relationship Between Lymphocytopenia and Circulating Tumor Cells as Prognostic Factors for Overall Survival in Metastatic Breast Cancer
    17 May 2012

    Ugo De Giorgi, Michal Mego, Emanuela Scarpi, Mario Giuliano, Antonio Giordano, James M. Reuben, Vicente Valero, Naoto T. Ueno, Gabriel N. Hortobagyi, Massimo Cristofanilli

  • Primary Malignant Fibrous Histiocytoma of the Breast: A Case Report and Review of 38 Chinese Cases
    23 April 2012

    Yue Hu, Xiuzhen Li, Yongchuan Deng, Meiqi Zhou, Suzhan Zhang

  • Small-Cell Cancer of the Breast: What Is the Optimal Treatment? A Report and Review of Outcomes
    23 April 2012

    Roberto Ochoa, Ashkay Sudhindra, Monica Garcia-Buitrago, Ada P. Romilly, Javier Cortes, Henry Gomez, Caio Max Rocha Lima, Orlando Silva

  • Primary Neuroendocrine Breast Carcinoma
    19 April 2012

    Pablo Menéndez, Esther García, Lorenzo Rabadán, Ricardo Pardo, David Padilla, Pedro Villarejo

  • View More Articles in Press...

On the Cover

Cover Image
Editor-in-Chief:
George W. Sledge, Jr, MD

Companion Journals

Attention Qualified Recipients

If you are a qualified recipient of the US print edition of Clinical Breast Cancer, click here to access the online edition.

Access this journal onSciVerse ScienceDirect
Print or Share This Page

About Clinical Breast Cancer

Clinical Breast Cancer is a peer-reviewed bimonthly journal that publishes original articles describing various aspects of clinical and translational research of breast cancer. Clinical Breast Cancer is devoted to articles on detection, diagnosis, prevention, and treatment of breast cancer. The main emphasis is on recent scientific developments in all areas related to breast cancer. Specific areas of interest include clinical research and mechanistic approaches; drug sensitivity and resistance; gene and antisense therapy; pathology, markers, and prognostic indicators; chemoprevention strategies; multimodality therapy; and integration of various approaches.

Clinical Breast Cancer is indexed by PubMed.

Journal Access

Full-text articles are available from 2000 to the present. Access to abstracts is complimentary. Access to full text is limited to personal subscribers.

Activate Online Access

Journal Ranking

2010 Journal Impact Factor: 2.790
© 2011 Thomson Reuters Journal Citation Reports

Publishing Information

Clinical Breast Cancer is published by Elsevier.